Results 181 to 190 of about 465,637 (309)
The Social Legitimacy of Targeted Welfare and Welfare Deservingness [PDF]
van Oorschot, Wim, Roosma, F.
openaire +2 more sources
Social welfare and economic equality: healthcare expenditure as a moderator. [PDF]
Liu G.
europepmc +1 more source
Optimal allocation of multi-type FACTS devices for mitigating wind power spillage with enhancing voltage stability and social welfare. [PDF]
Fawzy S, Abd-Raboh EE, Eladl AA.
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Spatial analysis of the percentages of smokers, alcohol drinkers, social welfare expenditure and insomniacs in Japan. [PDF]
Lotfy N, Tabuchi T.
europepmc +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
The impact of social welfare support on mental health in Vietnam. [PDF]
Vo DH, Huynh TL, Ho CM, Vo QT.
europepmc +1 more source
An Innovation Perspective to Explore the Ecology and Social Welfare Efficiencies of Countries. [PDF]
Liu ZJ, Le MH, Lu WM.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source

